Zobrazeno 1 - 10
of 258
pro vyhledávání: '"Rüdiger Müller"'
Autor:
Rüdiger Müller, Manuel Landstorfer
Publikováno v:
Entropy, Vol 25, Iss 3, p 416 (2023)
In this work, the balance equations of non-equilibrium thermodynamics are coupled to Galilean limit systems of the Maxwell equations, i.e., either to (i) the quasi-electrostatic limit or (ii) the quasi-magnetostatic limit. We explicitly consider a vo
Externí odkaz:
https://doaj.org/article/9ffe55d03b0544aeadcb27fdce75b519
Autor:
Lieve Van Hoovels, Xavier Bossuyt, Daniel Aletaha, Christopher Sjöwall, Stefanie Van den Bremt, Diego Kyburz, Alf Kastbom, Peggy Jacques, Laura Bogaert, Carolien Bonroy, Bert Vander Cruyssen, Ingmar Heijnen, Patrick Verschueren, Charlotte Dahle, Rille Pullerits, Saša Čučnik, Guenter Steiner, Daniela Sieghart, Eszter Nagy, Luca Bernasconi, Farid Benkhadra, Ann Van Liedekerke, Geert Vanheule, Johan Robbrecht, Lucy Studholme, Claudine Wirth, Rüdiger Müller, Rok Ješe, Boja Jovancevic, Emese Kiss
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/88134b10070c4d0282bcd632eff9704b
Publikováno v:
BMC Rheumatology, Vol 2, Iss 1, Pp 1-4 (2018)
Abstract Background We report the case of a patient with rheumatoid arthritis (RA) treated with tofacitinib who developed severe Pneumocystis jirovecii pneumonia (PJP) with an atypical clinical presentation. Case presentation A 78-year old male patie
Externí odkaz:
https://doaj.org/article/87f47aa27ce54ae0ad4ca5bd7cf10500
Autor:
Maria Kalweit, Ulrich A Walker, Axel Finckh, Rüdiger Müller, Gabriel Kalweit, Almut Scherer, Joschka Boedecker, Thomas Hügle
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252289 (2021)
BackgroundDeep neural networks learn from former experiences on a large scale and can be used to predict future disease activity as potential clinical decision support. AdaptiveNet is a novel adaptive recurrent neural network optimized to deal with h
Externí odkaz:
https://doaj.org/article/4fb44e422e2440d085807a0577cec8ba
Publikováno v:
Entropy, Vol 20, Iss 12, p 939 (2018)
We propose a modeling framework for magnetizable, polarizable, elastic, viscous, heat conducting, reactive mixtures in contact with interfaces. To this end, we first introduce bulk and surface balance equations that contain several constitutive quant
Externí odkaz:
https://doaj.org/article/8bf9b2d4f3614821a93e0f065ba75863
Publikováno v:
Swiss Medical Weekly, Vol 144, Iss 2728 (2014)
Biosimilars represent a new class of medicinal products that will have significant impact on clinical use. They are identical on an amino acid sequence level to existing reference biopharmaceutical products (originals). However, they may exhibit diff
Externí odkaz:
https://doaj.org/article/1b5468bd82c247c7ad476bfa04fbbd9e
Autor:
Lieve Van Hoovels, Lucy Studholme, Bert Vander Cruyssen, Daniela Sieghart, Carolien Bonroy, Eszter Nagy, Rille Pullerits, Sasa Čučnik, Charlotte Dahle, Ingmar Heijnen, Luca Bernasconi, Farid Benkhadra, Laura Bogaert, Stefanie Van Den Bremt, Ann Van Liedekerke, Geert Vanheule, Johan Robbrecht, Claudine Wirth, Rüdiger Müller, Diego Kyburz, Christopher Sjöwall, Alf Kastbom, Rok Ješe, Boja Jovancevic, Emese Kiss, Peggy Jacques, Daniel Aletaha, Günter Steiner, Patrick Verschueren, Xavier Bossuyt
Publikováno v:
ANNALS OF THE RHEUMATIC DISEASES
IntroductionCommercial assays measuring antibodies to citrullinated protein/peptide (ACPA) show poor quantitative agreement. The diagnostic industry has never adopted the International Union of Immunological Societies-Centers for Disease Control and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f4575246a12b753cc6b26509ac3a9b
https://lirias.kuleuven.be/handle/20.500.12942/699534
https://lirias.kuleuven.be/handle/20.500.12942/699534
Autor:
Prodromos Sidiropoulos, Simona Lopriore, Michael John Nissen, Alexandros A. Drosos, Matthew L. Thomas, Lenka Szczuková, Rachel Charlton, Richard Holland, Rüdiger Müller, Charlotte Cavill, Neil McHugh, Alison Nightingale, Michal Uher, Burkhard Möller, Jakub Zavada, Gavin Shaddick, Karel Pavelka, Irini Flouri, Almut Scherer, Giovanni Lapadula, Florenzo Iannone
Publikováno v:
Thomas, M, Shaddick, G, Charlton, R, Cavill, C, Holland, R, Iannone, F, Lapadula, G, Lopriore, S, Zavada, J, Uher, M, Pavelka, K, Szczukova, L, Sidiropolous, P, Flouri, I, Drosos, A, Möller, B, Nissen, M, Müller, R, Scherer, A, McHugh, N & Nightingale, A 2021, ' Tumour Necrosis Factor Inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases ', The Journal of Rheumatology, vol. 48, no. 1, pp. 48-57 . https://doi.org/10.3899/jrheum.190815
Objective.To investigate whether tumor necrosis factor inhibitor (TNFi) combination therapy with conventional synthetic disease-modifying antirheumatic drugs (csDMARD) is more effective for psoriatic arthritis (PsA) and/or improves TNFi drug survival